E-Scopics Receives FDA 510(k) Clearance for Hepatoscope-Derived Fat Fraction (HDFF) to Further Expand the Accessibility of Point-of-Care Non-Invasive Assessment of Fatty Liver
E-Scopics has secured FDA 510(k) clearance for its new Hepatoscope-Derived Fat Fraction (HDFF) technology, combining ultrasound attenuation with backscattering coefficient to measure liver fat. With a documented high correlation to MRI-PDFF, this innovation promises broader access to non-invasive fatty liver assessment.
3 days ago
2 mins read